In a study on both patient samples and HCC cell lines, it was discovered that miR-338-3p directly targeted HIF-1α and downregulated the expression of HIF-1α target genes involved in the hypoxia-induced signaling pathway. Here, HIF1A is linked to hepatocellular carcinoma.